Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4216

Similar articles for PubMed (Select 18702965)

2.

PP014. Estimating fully and minimal oxidized low density lipoprotein accumulation in placental tissue in intrauterine growth restriction and healthy controls.

Pecks U, Caspers R, Sosnowsky K, Rath W, Huppertz B.

Pregnancy Hypertens. 2012 Jul;2(3):248. doi: 10.1016/j.preghy.2012.04.125. Epub 2012 Jun 13.

PMID:
26105337
3.

1A.11: ASSOCIATION OF KIF6 AND HMGCR LOCI WITH CARDIOMETABOLIC PHENOTYPES AND RESPONSE TO STATIN THERAPY IN THE BRISIGHELLA COHORT.

Rosticci M, Marullo L, Cicero AF, Magi R, Fischer K, Pervjakova N, D'Addato S, Rizzoli E, Massimo G, Giovannini M, Angelini S, Scapoli C, Prokopenko I, Borghi C.

J Hypertens. 2015 Jun;33 Suppl 1:e3-4. doi: 10.1097/01.hjh.0000467361.35205.0a.

PMID:
26102786
4.

Risk factor burden and control at the time of admission in patients with acute myocardial infarction: Results from the NCDR.

Paixao AR, Enriquez JR, Wang TY, Li S, Berry JD, Khera A, Das SR, de Lemos JA, Kontos MC.

Am Heart J. 2015 Jul;170(1):173-179.e1. doi: 10.1016/j.ahj.2015.04.021. Epub 2015 Apr 24.

PMID:
26093879
5.

Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).

Spinler SA, Cziraky MJ, Willey VJ, Tang F, Maddox TM, Thomas T, Dueñas GG, Virani SS; NCDR.

Am J Cardiol. 2015 May 21. pii: S0002-9149(15)01335-1. doi: 10.1016/j.amjcard.2015.05.011. [Epub ahead of print]

PMID:
26089010
6.

Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients.

Saeedi R, Johns K, Frohlich J, Bennett MT, Bondy G.

Lipids Health Dis. 2015 Jun 19;14(1):57. doi: 10.1186/s12944-015-0054-x.

7.

[In what extend we can reach the current LDL-cholesterol treatment goals in secondary prevention].

Jr OM, Bruthans J.

Vnitr Lek. 2015 Spring;61(5):439-46. Czech.

PMID:
26075853
8.

To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.

Karlson BW, Palmer MK, Nicholls SJ, Lundman P, Barter PJ.

Atherosclerosis. 2015 Jun 3;241(2):450-454. doi: 10.1016/j.atherosclerosis.2015.05.029. [Epub ahead of print]

PMID:
26074319
9.

Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study).

Ballantyne CM, Braeckman RA, Bays HE, Kastelein JJ, Otvos JD, Stirtan WG, Doyle RT Jr, Soni PN, Juliano RA.

J Clin Lipidol. 2015 May-Jun;9(3):377-83. doi: 10.1016/j.jacl.2014.11.009. Epub 2014 Nov 29.

10.

Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance.

Thompson PD, Rubino J, Janik MJ, MacDougall DE, McBride SJ, Margulies JR, Newton RS.

J Clin Lipidol. 2015 May-Jun;9(3):295-304. doi: 10.1016/j.jacl.2015.03.003. Epub 2015 Mar 19.

11.

Consensus statement on the management of dyslipidemia in Indian subjects: A different perspective.

Enas EA, Dharmarajan TS, Varkey B.

Indian Heart J. 2015 Mar-Apr;67(2):95-102. doi: 10.1016/j.ihj.2015.03.020. Epub 2015 Apr 30. Review. No abstract available.

PMID:
26071285
12.

Statin treatment decreases serum angiostatin levels in patients with ischemic heart disease.

Tykhomyrov AA, Nedzvetsky VS, Bardachenko NI, Grinenko TV, Kuryata OV.

Life Sci. 2015 Aug 1;134:22-9. doi: 10.1016/j.lfs.2015.05.008. Epub 2015 May 30. No abstract available.

PMID:
26032258
13.

Serum Apolipoprotein-A1 and Cholesterol Levels in Nigerian Children with Plasmodium falciparum Infection.

Orimadegun AE, Orimadegun BE.

Med Princ Pract. 2015;24:318-24. doi: 10.1159/000430812. Epub 2015 May 27.

PMID:
26021459
14.

Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression.

Masson W, Siniawski D, Lobo M, Molinero G, Giorgi M, Huerín M.

Arq Bras Cardiol. 2015 May 19. pii: S0066-782X2015005050050. [Epub ahead of print] Portuguese, English.

15.

Low Prevalence of Elevated ApoB Levels in Patients with Type 2 Diabetes Not Receiving Lipid-Lowering Therapy.

Tildesley H, Fraser T, Wise S, Mazanderani A, Aydin C, Johns K, Yu E, Bondy G.

Can J Diabetes. 2009;33(3):163-9. doi: 10.1016/S1499-2671(09)33007-5. Epub 2012 Dec 10.

PMID:
25998591
16.

Effects of phenotypic and genotypic factors on the lipid responses to niacin in chinese patients with dyslipidemia.

Hu M, Yang YL, Ng CF, Lee CP, Lee VW, Hanada H, Masuda D, Yamashita S, Tomlinson B.

Medicine (Baltimore). 2015 May;94(20):e881. doi: 10.1097/MD.0000000000000881.

PMID:
25997070
17.

Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.

Krempf M, Simpson RJ Jr, Ramey DR, Brudi P, Giezek H, Tomassini JE, Lee R, Farnier M.

Lipids Health Dis. 2015 May 19;14:45. doi: 10.1186/s12944-015-0037-y.

18.

Adherence to statin therapy in patients with type 2 diabetes: An important dilemma.

Farsaei S, Sabzghabaee AM, Amini M, Zargarzadeh AH.

J Res Med Sci. 2015 Feb;20(2):109-14.

19.

The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report.

Li YF, Feng QZ, Gao WQ, Zhang XJ, Huang Y, Chen YD.

BMC Cardiovasc Disord. 2015 Feb 14;15:6. doi: 10.1186/1471-2261-15-6.

20.

The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.

Hovingh GK, Smits LP, Stefanutti C, Soran H, Kwok S, de Graaf J, Gaudet D, Keyserling CH, Klepp H, Frick J, Paolini JF, Dasseux JL, Kastelein JJ, Stroes ES.

Am Heart J. 2015 May;169(5):736-742.e1. doi: 10.1016/j.ahj.2015.01.008. Epub 2015 Jan 28.

PMID:
25965722
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk